Complete resolution of gastric amyloidosis after autologous stem cell transplantation

D. Cherian; K. Braun; N. Flomenberg; J. Palazzo; D. Kastenberg

doi:10.1055/s-2007-995793

Endoscopy, Inhaltsverzeichnis

Endoscopy 2008; 40: E167-E168
DOI: 10.1055/s-2007-995793

Unusual cases and technical notes

Complete resolution of gastric amyloidosis after autologous stem cell transplantation

D. Cherian¹ , K. Braun² , N. Flomenberg³ , J. Palazzo⁴ , D. Kastenberg²

¹Jefferson Medical College, Philadelphia, Pennsylvania, USA
²Division of Gastroenterology and Hepatology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
³Division of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
⁴Division of Pathology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA

Abstract

Volltext

Referenzen

References

1 Ebert E C, Nagar M. Gastrointestinal manifestations of amyloidosis. Am J Gastroenterol. 2007; 102 1-12
2 Chang H S, Myung S J, Yang S K. et al . Massive small bowel bleeding in a patient with amyloidosis. Gastrointest Endosc. 2004; 59 126-129
3 Gilat T, Spiro H M. Amyloidosis and the gut. Dig Dis Sci. 1968; 13 619-633
4 Comenzo R L, Vosburgh E, Falk R H. et al . Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. Blood. 1998; 91 3662-3670
5 Sanchorawala V, Wright D G, Seldin D C. et al . An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transplant. 2001; 28 637-642

D. Kastenberg, MD

Division of Gastroenterology and Hepatology

132 South 10th Street

Philadelphia

PA 19107

USA

Fax: +1-215-5032578

eMail: David.Kastenberg@jefferson.edu